The Ensign Group, Inc. has declared a quarterly cash dividend of $0.0650 per share of common stock, payable on or before July 31, 2026, to shareholders of record as of June 30, 2026. This announcement continues the company's dividend-paying history, which began in 2002.

The Ensign Group, Inc. is the parent company of the Ensign™ group of companies. Its independent operating subsidiaries provide skilled nursing and senior living services, physical, occupational and speech therapies, and other rehabilitative and healthcare services. The company operates across 396 healthcare facilities in multiple states, including Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin.

Dividend Details

The Ensign Group, Inc. invests in and provides a broad spectrum of healthcare services and real estate. More information about the company is available at its official website.

The Ensign Group, Inc. has increased its total authorized stock repurchase capacity to $100 million following a Board of Directors decision. The Board approved a $60 million addition to the previously authorized $40 million repurchase program. Repurchases under the expanded program are expected to commence in the near term, allowing the company to return additional capital to shareholders through open market purchases.

Authorization Details

The Ensign Group provides skilled nursing, senior living services, and rehabilitative and healthcare services. The company operates through its subsidiaries, which also engage in real estate investments related to its healthcare facilities.

The repurchase authorization allows the company to buy back shares periodically. The timing and actual volume of purchases will depend on market conditions and corporate requirements. The company is authorized to repurchase its issued and outstanding common shares from time to time in open-market and privately negotiated transactions and block trades in accordance with federal securities laws, including Rule 10b-18 and Rule 10b5-1.

Management Commentary

"Ensign's strong financial performance reflects the benefits of our proven business model built on clinical excellence, local leadership and a culture focused on providing compassionate, high-quality care for our residents," said Barry Port, Ensign's Chairman and Chief Executive Officer. He added that the increased authorization underscores confidence in the strength and upside potential of the company.